| Company Name: |
Beijing Comparison Pharmaceutical Technology Co., Ltd
|
| Tel: |
010-52878169 15701683040 |
| Email: |
sales@bjcomparison.com |
| Products Intro: |
Product Name:(2R,3R,4R,5R)-2-((R)-1,2-dihydroxyethyl)-5-(3-((5-(4- fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl) tetrahydrofuran-3,4-diol
CAS:2161394-94-9
Purity:99.22% Package:3g Remarks:KGJ086-17
|
| Company Name: |
Wuxi Zhongkun Biochemical Technology Co., Ltd.
|
| Tel: |
0510-85629785 18013409632 |
| Email: |
sales@reading-chemicals.com |
| Products Intro: |
Product Name:(2R,3R,4R,5R)-2-((R)-1,2-dihydroxyethyl)-5-(3-((5-(4- fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl) tetrahydrofuran-3,4-diol
CAS:2161394-94-9
Purity:95%+ Package:根据客户需求包装
|
|
| | Canagliflozin-10 Basic information |
| Product Name: | Canagliflozin-10 | | Synonyms: | (2R,3R,4R,5R)-2-((R)-1,2-dihydroxyethyl)-5-(3-((5-(4- fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl) tetrahydrofuran-3,4-diol;Canagliflozin impurity 9/(2R,3R,4R,5R)-2-((R)-1,2-dihydroxyethyl)-5-(3-((5-(4- fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl) tetrahydrofuran-3,4-diol;D-Galactitol, 1,4-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-;Canagliflozin Furanose Form (Mixture of Anomers);canagliflozin impurities613;canagliflozin impurities3;Canagliflozin-10 | | CAS: | 2161394-94-9 | | MF: | C24H25FO5S | | MW: | 444.52 | | EINECS: | | | Product Categories: | | | Mol File: | 2161394-94-9.mol |  |
| | Canagliflozin-10 Chemical Properties |
| Melting point | >53°C (dec) | | Boiling point | 673.5±55.0 °C(Predicted) | | density | 1.375±0.06 g/cm3(Predicted) | | storage temp. | Hygroscopic, -20°C Freezer, Under inert atmosphere | | solubility | DMSO (Slightly), Methanol (Slightly, Sonicated) | | pka | 13.56±0.70(Predicted) | | form | Solid | | color | White to Off-White | | Stability: | Hygroscopic |
| | Canagliflozin-10 Usage And Synthesis |
| Uses | 1-C-[3-[[5-(4-Fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucose is an intermediate used in the synthesis of Canagliflozin (C175190). Canagliflozin is a sodium/glucose cotransporter 2 (SGLT2) inhibitor; Canagliflozin is a candidate for the treatment of type 2 diabetes and obesity. |
| | Canagliflozin-10 Preparation Products And Raw materials |
|